|
| 惠泰医疗(688617)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-02-02 | 2168.55 | 32.43% | 6686.14 | 0.00 | 4517.59 | 67.57% | 首发原股东限售股份 | | 2023-12-19 | 1.03 | 0.02% | 4517.59 | 2168.55 | 4517.59 | 67.57% | 股权激励一般股份 | | 2023-06-28 | 18.11 | 0.27% | 4498.45 | 2168.55 | 4498.45 | 67.47% | 股权激励一般股份 | | 2023-01-09 | 66.68 | 1.00% | 4498.45 | 2168.55 | 4498.45 | 67.47% | 首发战略配售股份 | | 2022-01-07 | 2998.15 | 44.97% | 4431.77 | 2235.23 | 4431.77 | 66.47% | 首发战略配售股份,首发原股东限售股份 |
|